The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.
Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…
BOCA RATON, Fla., March 7, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced that…
For a long time, patients suffering from non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma only had one option to turn to for successful treatment. Mohs surgery, developed by general surgeon…
SRT-100 Vision a New Technology Revolutionizing Skin Cancer Treatment Skin cancer—it’s the most common cancer in the United States. An estimated one in five Americans will develop skin cancer in their lifetimes, but there’s a…
Dr. David Goldberg spoke at the 2017 South Beach Symposium conference on how SRT technology has rapidly advanced in the past 30 years and how SRT is an effective way to eradicate tumors while maintaining or…
